Soung, J., Tiu, L., Veverka, K. and Hong, C.-H. 2017. Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s26. DOI:https://doi.org/10.25251/skin.1.supp.25.